Published in Diabetes Care on August 31, 2010
Glycemic Control and Complications in Diabetes Mellitus Type 2 (VADT) (VADT) | NCT00032487
Cardiovascular disease and glycemic control in type 2 diabetes: now that the dust is settling from large clinical trials. Ann N Y Acad Sci (2013) 0.99
Diabetes and cardiovascular disease. Diabetes Care (2011) 0.86
Progression of vascular calcification is increased with statin use in the Veterans Affairs Diabetes Trial (VADT). Diabetes Care (2012) 0.84
Basic fibroblast growth factor predicts cardiovascular disease occurrence in participants from the veterans affairs diabetes trial. Front Endocrinol (Lausanne) (2013) 0.83
Atherosclerotic plaque inflammation varies between vascular sites and correlates with response to inhibition of lipoprotein-associated phospholipase A2. J Am Heart Assoc (2015) 0.81
The effect of intensive glucose lowering on lipoprotein particle profiles and inflammatory markers in the Veterans Affairs Diabetes Trial (VADT). Diabetes Care (2013) 0.81
The effect of intensive glucose lowering therapy among major racial/ethnic groups in the Veterans Affairs Diabetes Trial. Metabolism (2014) 0.79
Calcifications of vertebrobasilar arteries on CT: detailed distribution and relation to risk factors in 245 ischemic stroke patients. Biomed Res Int (2013) 0.78
Is Lipoprotein-Associated Phospholipase A2 a Link between Inflammation and Subclinical Atherosclerosis in Rheumatoid Arthritis? Biomed Res Int (2015) 0.77
A Link Between Hypoglycemia and Progression of Atherosclerosis in the Veterans Affairs Diabetes Trial (VADT). Diabetes Care (2016) 0.75
Advanced Glycation End Products, Oxidation Products, and the Extent of Atherosclerosis During the VA Diabetes Trial and Follow-up Study. Diabetes Care (2017) 0.75
A previously unreported impact of a PLA2G7 gene polymorphism on the plasma levels of lipoprotein-associated phospholipase A2 activity and mass. Sci Rep (2016) 0.75
Bone Mineral Density and Progression of Subclinical Atherosclerosis in African-Americans With Type 2 Diabetes. J Clin Endocrinol Metab (2016) 0.75
[Blood pressure goals on the test bench]. Wien Klin Wochenschr (2011) 0.75
Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med (2008) 25.70
Long-term prognosis associated with coronary calcification: observations from a registry of 25,253 patients. J Am Coll Cardiol (2007) 5.91
Coronary artery disease: improved reproducibility of calcium scoring with an electron-beam CT volumetric method. Radiology (1998) 4.48
Risk factors for the progression of coronary artery calcification in asymptomatic subjects: results from the Multi-Ethnic Study of Atherosclerosis (MESA). Circulation (2007) 3.90
Design of the cooperative study on glycemic control and complications in diabetes mellitus type 2: Veterans Affairs Diabetes Trial. J Diabetes Complications (2003) 3.33
Patterns and risk factors for systemic calcified atherosclerosis. Arterioscler Thromb Vasc Biol (2003) 2.72
Determinants of progression of coronary artery calcification in type 2 diabetes role of glycemic control and inflammatory/vascular calcification markers. J Am Coll Cardiol (2007) 2.29
Evaluating changes in coronary artery calcium: an analytic method that accounts for interscan variability. AJR Am J Roentgenol (2004) 2.26
Coronary artery and abdominal aortic calcification are associated with cardiovascular disease in type 2 diabetes. Diabetologia (2005) 2.03
Lipoprotein-associated phospholipase A2, platelet-activating factor acetylhydrolase, generates two bioactive products during the oxidation of low-density lipoprotein: use of a novel inhibitor. Biochem J (1999) 1.92
Intensive glucose-lowering therapy reduces cardiovascular disease events in veterans affairs diabetes trial participants with lower calcified coronary atherosclerosis. Diabetes (2009) 1.83
Markers of inflammation and coronary artery calcification: a systematic review. Atherosclerosis (2008) 1.71
Progression of coronary artery calcium and risk of first myocardial infarction in patients receiving cholesterol-lowering therapy. Arterioscler Thromb Vasc Biol (2004) 1.45
Association of multiple risk factors and insulin resistance with increased prevalence of asymptomatic coronary artery disease by an electron-beam computed tomographic study. Arterioscler Thromb Vasc Biol (2001) 1.42
Progression of coronary artery calcium and occurrence of myocardial infarction in patients with and without diabetes mellitus. Hypertension (2005) 1.37
Association of lipoprotein-associated phospholipase A2 mass and activity with calcified coronary plaque in young adults: the CARDIA study. Arterioscler Thromb Vasc Biol (2004) 1.30
Blood pressure and fasting plasma glucose rather than metabolic syndrome predict coronary artery calcium progression: the Rancho Bernardo Study. Diabetes Care (2008) 1.26
Diabetes and progression of coronary calcium under the influence of statin therapy. Am Heart J (2005) 1.09
Effect of simvastatin (80 mg) on coronary and abdominal aortic arterial calcium (from the coronary artery calcification treatment with zocor [CATZ] study). Am J Cardiol (2007) 1.09
Aortic calcification in haemodialysis patients with diabetes mellitus. Nephrol Dial Transplant (2005) 1.07
Reduced coronary artery and abdominal aortic calcification in Hispanics with type 2 diabetes. Diabetes Care (2004) 1.00
Progression of coronary artery calcium in type 1 diabetes mellitus. Am J Cardiol (2007) 0.95
The progress of coronary heart disease in Type 2 diabetes as measured by coronary calcium score from electron beam computed tomography (EBCT): the PREDICT study. Atherosclerosis (2007) 0.88
[Current studies on the progression of coronary calcification]. MMW Fortschr Med (2007) 0.78
Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med (2008) 25.70
Coronary-artery revascularization before elective major vascular surgery. N Engl J Med (2004) 7.80
Public expectations and attitudes for annual physical examinations and testing. Ann Intern Med (2002) 4.41
Pioglitazone for diabetes prevention in impaired glucose tolerance. N Engl J Med (2011) 4.28
Follow-up of glycemic control and cardiovascular outcomes in type 2 diabetes. N Engl J Med (2015) 3.67
Long-term patency of saphenous vein and left internal mammary artery grafts after coronary artery bypass surgery: results from a Department of Veterans Affairs Cooperative Study. J Am Coll Cardiol (2004) 2.99
Nutrient modification of the innate immune response: a novel mechanism by which saturated fatty acids greatly amplify monocyte inflammation. Arterioscler Thromb Vasc Biol (2010) 2.42
Support of evidence-based guidelines for the annual physical examination: a survey of primary care providers. Arch Intern Med (2005) 2.25
The use of zoledronic acid in men receiving androgen deprivation therapy for prostate cancer with severe osteopenia or osteoporosis. Urology (2010) 2.14
Autoantibodies to oxidized LDL and cardiovascular risk: the Framingham Offspring Study. Atherosclerosis (2006) 2.04
The association of contact lens solution use and Acanthamoeba keratitis. Am J Ophthalmol (2007) 1.97
Physician and public opinions on quality of health care and the problem of medical errors. Arch Intern Med (2002) 1.95
Residents' patient-specific clinical questions: opportunities for evidence-based learning. Acad Med (2005) 1.89
Predictors and outcomes of a perioperative myocardial infarction following elective vascular surgery in patients with documented coronary artery disease: results of the CARP trial. Eur Heart J (2008) 1.87
Intensive glucose-lowering therapy reduces cardiovascular disease events in veterans affairs diabetes trial participants with lower calcified coronary atherosclerosis. Diabetes (2009) 1.83
Exenatide suppresses postprandial elevations in lipids and lipoproteins in individuals with impaired glucose tolerance and recent onset type 2 diabetes mellitus. Atherosclerosis (2010) 1.80
Macrophage-secreted factors induce adipocyte inflammation and insulin resistance. Biochem Biophys Res Commun (2006) 1.74
Visual acuity loss and clinical observations in a large series of patients with Stargardt disease. Ophthalmology (2003) 1.69
Discrimination between obesity and insulin resistance in the relationship with adiponectin. Diabetes (2004) 1.58
A new method for grading the severity of keratoconus: the Keratoconus Severity Score (KSS). Cornea (2006) 1.49
Perioperative complications after vascular surgery are predicted by the revised cardiac risk index but are not reduced in high-risk subsets with preoperative revascularization. Circ Cardiovasc Qual Outcomes (2009) 1.48
Preoperative coronary artery revascularization and long-term outcomes following abdominal aortic vascular surgery in patients with abnormal myocardial perfusion scans: a subgroup analysis of the coronary artery revascularization prophylaxis trial. Catheter Cardiovasc Interv (2011) 1.45
Assessing metabolic acidosis in the intensive care unit: does the method make a difference? Crit Care Med (2004) 1.44
Food frequency questionnaire results correlate with metabolic control in insulin-treated veterans with type 2 diabetes: the Diabetes Outcomes in Veterans Study. J Am Diet Assoc (2004) 1.42
Ethnicity, race, and baseline retinopathy correlates in the veterans affairs diabetes trial. Diabetes Care (2005) 1.40
Direct-to-consumer pharmaceutical advertising: physician and public opinion and potential effects on the physician-patient relationship. Arch Intern Med (2004) 1.32
Postprandial hyperlipidemia, endothelial dysfunction and cardiovascular risk: focus on incretins. Cardiovasc Diabetol (2011) 1.31
Blood pressure and cardiovascular disease risk in the Veterans Affairs Diabetes Trial. Diabetes Care (2010) 1.31
Contributions of weekly mean blood glucose values to hemoglobin A1c in insulin-treated type 2 diabetes: the Diabetes Outcomes in Veterans Study (DOVES). Am J Med Sci (2004) 1.30
The duration of diabetes affects the response to intensive glucose control in type 2 subjects: the VA Diabetes Trial. J Diabetes Complications (2011) 1.29
Veterans Affairs diabetes trial--corrections. N Engl J Med (2009) 1.25
Meta-analysis of clinical outcomes following surgical mitral valve repair or replacement. Eur J Cardiothorac Surg (2006) 1.24
Improvement of postprandial endothelial function after a single dose of exenatide in individuals with impaired glucose tolerance and recent-onset type 2 diabetes. Diabetes Care (2010) 1.23
Pioglitazone slows progression of atherosclerosis in prediabetes independent of changes in cardiovascular risk factors. Arterioscler Thromb Vasc Biol (2012) 1.22
An insulin-degrading enzyme inhibitor decreases amylin degradation, increases amylin-induced cytotoxicity, and increases amyloid formation in insulinoma cell cultures. Diabetes (2003) 1.21
Intensified blood glucose monitoring improves glycemic control in stable, insulin-treated veterans with type 2 diabetes: the Diabetes Outcomes in Veterans Study (DOVES). Diabetes Care (2003) 1.20
Exercise training is not associated with improved levels of C-reactive protein or adiponectin. Metabolism (2005) 1.18
Actos Now for the prevention of diabetes (ACT NOW) study. BMC Endocr Disord (2009) 1.15
Palmitic acid induces IP-10 expression in human macrophages via NF-kappaB activation. Biochem Biophys Res Commun (2007) 1.12
Predictors of cognitive decline following coronary artery bypass graft surgery. Ann Thorac Surg (2004) 1.11
Trends in anticoagulation for atrial fibrillation in the U.S.: an analysis of the national ambulatory medical care survey database. J Am Coll Cardiol (2007) 1.09
Does aggressive glycemic control benefit macrovascular and microvascular disease in type 2 diabetes? Insights from ACCORD, ADVANCE, and VADT. Curr Cardiol Rep (2012) 1.06
Urinary excretion of three nucleic acid oxidation adducts and isoprostane F(2)alpha measured by liquid chromatography-mass spectrometry in smokers, ex-smokers, and nonsmokers. Free Radic Biol Med (2003) 1.04
Differential effects of metformin and troglitazone on cardiovascular risk factors in patients with type 2 diabetes. Diabetes Care (2002) 1.03
A probabilistic model for predicting hypoglycemia in type 2 diabetes mellitus: The Diabetes Outcomes in Veterans Study (DOVES). Arch Intern Med (2004) 1.03
Quantification of 8-iso-prostaglandin-F(2alpha) and 2,3-dinor-8-iso-prostaglandin-F(2alpha) in human urine using liquid chromatography-tandem mass spectrometry. Free Radic Biol Med (2003) 1.03
Racial and ethnic disparities in the control of cardiovascular disease risk factors in Southwest American veterans with type 2 diabetes: the Diabetes Outcomes in Veterans Study. BMC Health Serv Res (2006) 1.03
Selective apoptotic killing of malignant hemopoietic cells by antibody-targeted delivery of an amphipathic peptide. Cancer Res (2005) 1.02
Prediction of diabetes based on baseline metabolic characteristics in individuals at high risk. Diabetes Care (2013) 1.01
Ethnicity, race, and clinically significant macular edema in the Veterans Affairs Diabetes Trial (VADT). Diabetes Res Clin Pract (2009) 1.01
Ethnic differences in the relationship between adiponectin and insulin sensitivity in South Asian and Caucasian women. Diabetes Care (2008) 1.00
The third person in the room: frequency, role, and influence of companions during primary care medical encounters. J Fam Pract (2002) 0.99
Association between IL-6 and the extent of coronary atherosclerosis in the veterans affairs diabetes trial (VADT). Atherosclerosis (2008) 0.98
Prevention of diabetes with pioglitazone in ACT NOW: physiologic correlates. Diabetes (2013) 0.97
Pioglitazone inhibits the expression of inflammatory cytokines from both monocytes and lymphocytes in patients with impaired glucose tolerance. Arterioscler Thromb Vasc Biol (2008) 0.97
Short-term inter-visit variability of erg amplitudes in normal subjects and patients with retinitis pigmentosa. Retina (2005) 0.97
Endpoint refinement for total body irradiation of C57BL/6 mice. Comp Med (2013) 0.95
Sources of glucose variability in insulin-treated type 2 diabetes: the Diabetes Outcomes in Veterans Study (DOVES). Clin Endocrinol (Oxf) (2004) 0.95
Improvements in insulin resistance with weight loss, in contrast to rosiglitazone, are not associated with changes in plasma adiponectin or adiponectin multimeric complexes. Am J Physiol Regul Integr Comp Physiol (2006) 0.93
Molecular and signaling mechanisms of atherosclerosis in insulin resistance. Endocrinol Metab Clin North Am (2006) 0.93
A coastal seawater temperature dataset for biogeographical studies: large biases between in situ and remotely-sensed data sets around the Coast of South Africa. PLoS One (2013) 0.92
Induction of monocyte differentiation and foam cell formation in vitro by 7-ketocholesterol. J Lipid Res (2002) 0.91
Biological age--a concept whose time has come: a preliminary study. South Med J (2005) 0.91
Peroxisome proliferator-activated receptor-alpha and atherosclerosis: from basic mechanisms to clinical implications. Cardiol Rev (2005) 0.91
Lipolysis of triglyceride-rich lipoproteins, vascular inflammation, and atherosclerosis. Biochim Biophys Acta (2011) 0.91
Insulin metabolism in human adipocytes from subcutaneous and visceral depots. Biochem Biophys Res Commun (2010) 0.90
Proliferative diabetic retinopathy in type 2 diabetes is related to coronary artery calcium in the Veterans Affairs Diabetes Trial (VADT). Diabetes Care (2008) 0.90
Inhibition of proteasome activity by selected amino acids. Metabolism (2003) 0.90
Regulation of protein degradation by insulin-degrading enzyme: analysis by small interfering RNA-mediated gene silencing. Arch Biochem Biophys (2007) 0.89
Hypoglycemia in stable, insulin-treated veterans with type 2 diabetes: a prospective study of 1662 episodes. J Diabetes Complications (2005) 0.88
Effect of environmental conditions and leafhopper gender on Maize chlorotic dwarf virus transmission by Graminella nigrifrons (Homoptera: Cicadellidae). J Econ Entomol (2004) 0.87
Albumin activates the AKT signaling pathway and protects B-chronic lymphocytic leukemia cells from chlorambucil- and radiation-induced apoptosis. Blood (2002) 0.87
Comparison of dilated fundus examinations with seven-field stereo fundus photographs in the Veterans Affairs Diabetes Trial. J Diabetes Complications (2008) 0.87
Usefulness of revascularization of patients with multivessel coronary artery disease before elective vascular surgery for abdominal aortic and peripheral occlusive disease. Am J Cardiol (2008) 0.86
Progression of vascular calcification is increased with statin use in the Veterans Affairs Diabetes Trial (VADT). Diabetes Care (2012) 0.84
Pioglitazone reduces inflammatory responses of human adipocytes to factors secreted by monocytes/macrophages. Am J Physiol Endocrinol Metab (2009) 0.84
Impact of a simple intervention to increase primary care provider recognition of patient referral concerns. Am J Manag Care (2002) 0.84
Beneficial effects of a glyburide/metformin combination preparation in type 2 diabetes mellitus. Am J Med Sci (2003) 0.84
Human thyroid phenol sulfotransferase enzymes 1A1 and 1A3: activities in normal and diseased thyroid glands, and inhibition by thyroid hormones and phytoestrogens. J Clin Endocrinol Metab (2004) 0.83
Basic fibroblast growth factor predicts cardiovascular disease occurrence in participants from the veterans affairs diabetes trial. Front Endocrinol (Lausanne) (2013) 0.83
Coronary artery bypass grafting is superior to percutaneous coronary intervention in prevention of perioperative myocardial infarctions during subsequent vascular surgery. Ann Thorac Surg (2006) 0.83
Anti-neurotrophic effects from autoantibodies in adult diabetes having primary open angle glaucoma or dementia. Front Endocrinol (Lausanne) (2013) 0.83
Health-related quality of life in the VA Feasibility Study on glycemic control and complications in type 2 diabetes mellitus. J Diabetes Complications (2005) 0.83
Observation on renal outcomes in the Veterans Affairs Diabetes Trial. Diabetes Care (2011) 0.83
Baseline achievement of lipid goals and usage of lipid medications in patients with diabetes mellitus (from the Veterans Affairs Diabetes Trial). Am J Cardiol (2006) 0.83
Plasma adiponectin concentrations do not increase in association with moderate weight loss in insulin-resistant, obese women. Metabolism (2004) 0.83